Number of the records: 1  

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

  1. 1.
    SYSNO0571076
    TitleType I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
    Author(s) Holíček, P. (CZ)
    Truxová, I. (CZ)
    Raková, J. (CZ)
    Šálek, C. (CZ)
    Hensler, M. (CZ)
    Kovář, Marek (MBU-M) RID, ORCID
    Reiniš, Milan (UMG-J) [11] RID
    Mikyšková, Romana (UMG-J) [11] RID
    Pasulka, J. (CZ)
    Vošahlíková, Š. (CZ)
    Remešová, H. (CZ)
    Valentová, I. (CZ)
    Lysák, D. (CZ)
    Holubová, M. (CZ)
    Kašpar, Petr (UMG-J) [18] RID
    Procházka, Jan (UMG-J) [18] ORCID
    Kašíková, L. (CZ)
    Špíšek, R. (CZ)
    Galluzzi, L. (US)
    Fučiková, J. (CZ)
    Corespondence/seniorGalluzzi, L. - Korespondující autor
    Fučiková, J. - Korespondující autor
    Source Title Cell Death & Disease. Roč. 14, č. 3 (2023). - : Springer
    Article number209
    Document TypeČlánek v odborném periodiku
    Grant LM2023036 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportMBU-M - RVO:61388971 ; UMG-J - RVO:68378050
    Languageeng
    CountryDE
    Keywords acute myeloid-leukemia * alpha * cells * metastasis * signature * radiation * rna
    Cooperating institutions Sotio AS, Praha (Czech Republic)
    Univerzita Karlova v Praze, 2. lékařská fakulta (Czech Republic)
    Fakultní nemocnice v Motele (Czech Republic)
    Ústav hematologie a krevní transfuze (Czech Republic)
    Univerzita Karlova v Praze, 1. lékařská fakulta (Czech Republic)
    Fakultní nemocnice Plzeň-Lochotín (Czech Republic)
    URLhttps://www.nature.com/articles/s41419-023-05728-w
    Permanent Linkhttps://hdl.handle.net/11104/0342383
    FileDownloadSizeCommentaryVersionAccess
    Type I interferon signaling.pdf01.4 MBPublisher’s postprintopen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.